Month: September 2020
Notice of third quarter 2020 results and conference call Luxembourg, September 25, 2020 – Millicom will announce its third quarter results on October 30, 2020 at approximately 11:00 (Stockholm) / 10:00 (London) / 06:00 (Miami) via a press release.The company will host a conference call for the global financial community on October 30, 2020 at 13:00 (Stockholm) / 12:00 (London) / 08:00 (Miami).The conference call will be webcast at millicom.comDial-in information:Please dial in 5-10 minutes before the scheduled start time to register your attendance. Dial-in numbers for the call are as follows:Sweden: +46 (0) 8566-19361 Luxembourg: +352-2786-6996UK: +44 (0) 2031-070289 US: +1-914-987-7208The access code is: 4064116Replay information:A replay...
YANGAROO Announces The Launch Of EZ Downloads; Software-Free Secure Watermarked Cloud-Based Downloads
Written by Customer Service on . Posted in Public Companies.
TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (“Yangaroo”, “Company”), (TSX-V: YOO, OTCBB: YOOIF), the software leader in workflow management and media distribution solutions, today announced the launch of a major upgrade to its cloud-based Yangaroo Music distribution platform. The Yangaroo Music platform runs on Yangaroo’s DMDS workflow solution for Media and Entertainment companies based entirely in the cloud. DMDS users, including professionals in radio, media and other promotional music outlets, are now able to download new music and accompanying promo assets directly through their web browser with the same efficiency and security as using the existing application interface. This update has been dubbed EZ Downloads and provides a significant market advantage over competing services, making Yangaroo Music and DMDS...
Cabaletta Bio to Present at Upcoming Investor Conferences in October
Written by Customer Service on . Posted in Public Companies.
PHILADELPHIA, Sept. 25, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the following three upcoming investor conferences in October:Stifel 2020 Immunology and Inflammation Virtual Summit: “The Potential for Treg Modifying and CAR T Therapies in Immunology” panel on Thursday, October 1, 2020 at 3:00 p.m. ET.Jefferies Virtual Cell Therapy Summit: Fireside chat on Monday, October 5, 2020 at 8:30 a.m. ET.Chardan 4thAnnual Genetic Medicines Conference: Fireside chat on Tuesday, October 6, 2020 at 11:30 a.m. ET.A live webcast of these presentations will be available...
Graybug Appoints Three New Members to its Board of Directors
Written by Customer Service on . Posted in Public Companies.
REDWOOD CITY, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the appointment of three new members to the company’s Board of Directors with immediate effect. Christina Ackermann will chair Graybug’s Nominating and Corporate Governance Committee and serve as a member of its Compensation Committee. Eric Bjerkholt, MBA, will chair the company’s Compensation Committee and serve as a member of the Audit Committee. Julie Eastland, MBA, will chair the Audit Committee.Ms. Ackermann, Mr. Bjerkholt and Ms. Eastland replace Emmett Cunningham, Jr., MD, PhD, Managing Director at Blackstone Lifesciences Group, Chau Q. Khuong, MPH, Partner...
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
Written by Customer Service on . Posted in Public Companies.
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., senior vice president of translational research, will present at the Stifel Immunology and Inflammation Virtual Summit. Dr. Blouse will speak on a panel entitled: “The evolution of complement targeted therapies,” taking place on Thursday, October 1, 2020, at 9:00 AM Eastern Time.To access a live webcast of the panel presentation, please click here.An archived webcast of the presentation will be available for 90 days on the Events and Presentations section on the Company’s website.About Catalyst BiosciencesCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Our protease engineering...
Kratos Awarded $950 Million Multiple-Award, IDIQ Contract for U.S. Air Force Advanced Battle Management System (ABMS)
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, Sept. 25, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has been awarded a $950,000,000 ceiling indefinite-delivery/indefinite-quantity contract for the maturation, demonstration and proliferation of capability across platforms and domains, leveraging open systems design, modern software and algorithm development in order to enable Joint All Domain Command and Control (JADC2). This contract is part of a multiple award multi-level security effort to provide development and operation of systems as a unified force across all domains (air, land, sea, space, cyber, and electromagnetic spectrum) in an open architecture family of systems that enables capabilities via multiple integrated platforms.Kratos offers solutions...
Rogers announces comprehensive $3 billion investment proposal to benefit Quebec
Written by Customer Service on . Posted in Public Companies.
Rogers unveils investments to honour Cogeco’s legacy, expand rural connectivity, accelerate 5G coverage to 95% of Quebecers and create hundreds of highly skilled jobs with new tech innovation hubMONTREAL and TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — After 35 years of building in Quebec, Rogers today unveiled a $3 billion investment proposal to bring connectivity, jobs and economic growth to Quebec should it be successful in its bid to acquire Cogeco’s Canadian assets.“Rogers is deeply committed to the future of innovation and the knowledge economy in Quebec. We would be honoured to help enhance the customer experience and bring new investments including 5G that will fundamentally reshape the economic landscape of Quebec,” said Joe Natale, President and CEO, Rogers Communications. “This is about the future, and helping ensure that...
Bombardier celebrates unveiling of train design for India’s first semi-high-speed RRTS corridor
Written by Customer Service on . Posted in Public Companies.
India’s first Regional Rapid Transit System (RRTS) will operate one of the fastest trains in India with a design speed of 180 kilometers per hour reducing travel time between Meerut and Delhi to less than 60 minutesSleek modern train design is inspired by Delhi’s iconic monument The Lotus TempleBERLIN, Sept. 25, 2020 (GLOBE NEWSWIRE) —Note to editors: To view the photo and the PDF document associated with this press release, please visit the following links:Today, global mobility technology leader Bombardier Transportation and India’s National Capital Region Transport Corporation (NCRTC) celebrated the unveiling of train design for India’s first Regional Rapid Transit System (RRTS). The train design was unveiled by Durga Shanker Mishra, Secretary, Ministry of Housing and Urban Affairs, Government of India in the presence of Vinay...
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
Written by Customer Service on . Posted in Public Companies.
NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an implementation and equipment financing partnership with AID Genomics, a multi-national genomic R&D company and solution provider focusing on precision medicines for cancers and infectious diseases. AID Genomics recently completed a contract with the Ministry of Health in Israel to build and scale-up 6 HMO laboratories in Israel. In addition, AID Genomics has entered into a worldwide partnership with Tecan Group for delivery of liquid handler machines....
Weyland Tech Begins Trading Under New Company Name, Logiq, and Ticker Symbol, LGIQ
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) — Logiq, Inc. (formerly Weyland Tech) (OTCQX: WEYL) (OTCQX:LGIQ), a global provider of award-winning eCommerce solutions, has received notification from the Financial Industry Regulatory Authority (FINRA) that its new name, Logiq, Inc., would take effect on the over-the-counter market on September 25, 2020. At the open of trading today, on September 25, 2020, the company commenced trading of its common stock under the new name, Logiq, Inc., and its ticker symbol changed from “WEYL” to “LGIQ.”“Our new name and ticker reflects our evolution from operating primarily as a mCommerce services company to becoming a leading innovator of data-driven consumer intelligence and marketing technology,” said Logiq CEO, Tom Furukawa. “We’ve now entered a new stage of accelerated growth and development.”Over...
